The Involvement of Age, Gender, and Personality Variables in Alcohol Consumption during the Start of the COVID-19 Pandemic in Romanian University Students.

Publication date: Jun 20, 2023

This study aimed to explore the age, gender, and personality variables involved in alcohol consumption (AC) at the start of the COVID-19 pandemic in Romania among 210 bachelor’s and master’s students aged between 19 and 25 years. The results of the Freiburg Personality Inventory-Revised and the Alcohol Use Disorders Identification Test were examined using a logistic model and cluster analysis. The prevalence of problematic AC was relatively low (10. 5%). The risk of males being part of the problematic AC cluster was 5. 223 times higher than that of females (p < 0. 001). Increasing age was associated with a decrease in the risk of belonging to the problematic cluster by a factor of 0. 733 (p = 0. 001). Increasing scores on the Frankness and Somatic Complaints personality scales were associated with a decreased risk of belonging to the problematic cluster of AC, with factors of 0. 738 (95% CI, 0. 643 to 0. 848), Wald χ(1) = 18. 424, and p < 0. 001 and 0. 901 (95% CI, 0. 813 to 0. 999), Wald χ(1) = 3. 925, and p = 0. 048, respectively. More action to prevent AC is needed in men, especially in those at the beginning of their university studies. It is necessary to intervene to decrease the interest in making a good impression (low scores on the Frankness Scale) so as to increase healthy autonomy using critical thinking and find a balance between the internal and external loci of control. Students from faculties with profiles that deal with health and its promotion are less vulnerable to problematic alcohol consumption, even if they have a withdrawn, pessimistic personality (low scores on Somatic Complaints).

Open Access PDF

Concepts Keywords
Bachelor alcohol consumption
Pessimistic COVID-19 pandemic
Romania personality
Students university students


Type Source Name
disease VO age
drug DRUGBANK Ethanol
disease MESH COVID-19 Pandemic
disease MESH Alcohol Use Disorders
drug DRUGBANK Isoxaflutole
drug DRUGBANK Coenzyme M
disease MESH death
disease MESH communicable diseases
disease MESH infections
disease MESH cancer
pathway REACTOME Immune System
disease VO organization
disease VO population
disease MESH impulsivity
disease MESH neuroticism
disease MESH cyclothymia
disease VO time
disease MESH anxiety disorders
disease VO frequency
drug DRUGBANK Gold
drug DRUGBANK Bean
drug DRUGBANK Methionine
disease MESH mood disorders
disease MESH drunkenness
disease IDO susceptibility
disease VO USA
disease MESH perfectionism
disease MESH post traumatic stress disorder
disease IDO intervention
disease VO Gap
drug DRUGBANK Spinosad
disease MESH emotional distress
drug DRUGBANK Etodolac
drug DRUGBANK Medical Cannabis
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH marijuana use
drug DRUGBANK Trestolone
disease MESH Loneliness
disease VO Apa

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *